Conventional type 1 dendritic cells (cDC1) in cancer immunity

Cancer immunotherapy, alone or in combination with conventional therapies, has revolutionized the landscape of antineoplastic treatments, with dendritic cells (DC) emerging as key orchestrators of anti-tumor immune responses. Among the distinct DC subsets, conventional type 1 dendritic cells (cDC1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Zhao, Liwei, Kroemer, Guido, Kepp, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619282/
https://www.ncbi.nlm.nih.gov/pubmed/37907944
http://dx.doi.org/10.1186/s13062-023-00430-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619282/
https://www.ncbi.nlm.nih.gov/pubmed/37907944
http://dx.doi.org/10.1186/s13062-023-00430-5

Ejemplares similares